CK-0045
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CK-0045, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes [Phase 2]